AOD9604

Source / Derivation:

AOD9604 is a synthetic fragment of human growth hormone (GH), specifically the C-terminal 176–191 region responsible for GH’s lipolytic activity. This fragment retains metabolic-signaling effects without exhibiting the growth-promoting properties associated with full-length GH.

AOD9604

Mechanism of Action:

AOD9604 modulates lipid-mobilizing pathways by enhancing lipolysis and inhibiting lipogenesis, acting independently of IGF-1–mediated growth mechanisms. It influences β-adrenergic–related signaling and facilitates the breakdown of stored triglycerides in adipose tissue.

Clinical Relevance & Potential Outcomes:

Studies suggest that AOD9604 may support fat-metabolism pathways, improvements in adipose distribution, and enhanced metabolic efficiency. Preliminary findings also indicate potential benefits in joint comfort and cartilage metabolism due to secondary anti-inflammatory and reparative signals.

Intended Clinical Application:

AOD9604 may be considered for individuals seeking assistance with fat-metabolism balance, body-composition support, or adjunctive metabolic optimization, particularly in programs focused on reducing adiposity while preserving lean mass.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

10 mg/ml, total 3 ml, total 30 mg

Daily

1 month

A modified fragment of human growth hormone that promotes fat metabolism and weight loss without affecting blood sugar or muscle growth.